Skip to main content

Talazoparib Tosylate Capsule Shortage

Last Updated: January 13, 2025
Status: Discontinued

To Be Discontinued:

Talzenna, Capsule, .1 mg (Pfizer Inc.)

NDC Code: 0069-1031-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0252-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Talzenna, Capsule, .25 mg (Pfizer Inc.)

NDC Code: 0069-0296-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0353-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Talzenna, Capsule, .35 mg (Pfizer Inc.)

NDC Code: 0069-1235-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0454-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Talzenna, Capsule, .5 mg (Pfizer Inc.)

NDC Code: 0069-1501-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0546-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Talzenna, Capsule, .75 mg (Pfizer Inc.)

NDC Code: 0069-1751-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0655-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Talzenna, Capsule, 1 mg (Pfizer Inc.)

NDC Code: 0069-1195-30
Status: To Be Discontinued
Date of update: January 13, 2025
Update type: New
Related Information: Supply expected to exhaust late February 2025 Replaced with Soft Gel NDC 0069-0757-30
Therapeutic category: Oncology
Date discontinued: January 13, 2025
Initial posting date: January 13, 2025
Contact info: 800-533-4535

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer